Insulin Transport into the Brain and Cerebrospinal Fluid

Vitamins and Hormones

Volumn 98, Issue , 2015, Pages 229-248

  Begg, Denovan P ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Adiposity; Blood brain barrier; Central nervous system; Cerebrospinal fluid; Insulin; Receptor mediated transport

Indexed keywords

GLUCOSE BLOOD LEVEL; INSULIN; INSULIN RECEPTOR;

ANIMAL; BLOOD BRAIN BARRIER; BRAIN; CEREBROSPINAL FLUID; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HUMAN; METABOLISM; OBESITY; PHYSIOLOGY; RISK FACTOR; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; BIOLOGICAL TRANSPORT; BLOOD GLUCOSE; BLOOD-BRAIN BARRIER; BRAIN; DIABETES MELLITUS; HUMANS; INSULIN; OBESITY; RECEPTOR, INSULIN; RISK FACTORS;

EID: 84955634160     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/bs.vh.2014.12.007     Document Type: Chapter

References (145)

1. Ahren B. Autonomic regulation of islet hormone secretion-Implications for health and disease. Diabetelogia 2000, 43(4):393-410.
2. Ahren B., Holst J.J. The cephalic insulin response to meal ingestion in humans is dependent on both cholinergic and noncholinergic mechanisms and is important for postprandial glycemia. Diabetes 2001, 50(5):1030-1038.
3. Air E.L., Benoit S.C., Blake Smith K.A., Clegg D.J., Woods S.C. Acute third ventricular administration of insulin decreases food intake in two paradigms. Pharmacology, Biochemistry & Behavior 2002, 72(1-2):423-429.
4. Air E.L., Benoit S.C., Clegg D.J., Seeley R.J., Woods S.C. Insulin and leptin combine additively to reduce food intake and body weight in rats. Endocrinology 2002, 143(6):2449-2452.
5. Andersen D.K., Elahi D., Brown J.C., Tobin J.D., Andres R. Oral glucose augmentation of insulin secretion. Interactions of gastric inhibitory polypeptide with ambient glucose and insulin levels. The Journal of Clinical Investigation 1978, 62(1):152-161.
6. Aponte G., Leung P., Gross D., Yamada T. Effects of somatostatin on food intake in rats. Life Sciences 1984, 35(7):741-746.
7. Arase K., Fisler J.S., Shargill N.S., York D.A., Bray G.A. Intracerebroventricular infusions of 3-OHB and insulin in a rat model of dietary obesity. American Journal of Physiology 1988, 255:R974-R981.
8. Asakawa A., Inui A., Ueno N., Fujimiya M., Fujino M.A., Kasuga M. Mouse pancreatic polypeptide modulates food intake, while not influencing anxiety in mice. Peptides 1999, 20(12):1445-1448.
9. Bagdade J.D. Basal insulin and obesity. Lancet 1968, 2:630-631.
10. Bagdade J.D., Bierman E.L., Porte D. The significance of basal insulin levels in the evaluation of the insulin response to glucose in diabetic and nondiabetic subjects. The Journal of Clinical Investigation 1967, 46:1549-1557.
11. Banks W.A. The source of cerebral insulin. European Journal of Pharmacology 2004, 490:5-12.
12. Banks W.A., DiPalma C.R., Farrell C.L. Impaired transport of leptin across the blood-brain barrier in obesity. Peptides 1999, 20(11):1341-1345.
13. Banks W.A., Jaspan J.B., Huang W., Kastin A.J. Transport of insulin across the blood-brain barrier: Saturability at euglycemic doses of insulin. Peptides 1997, 18:1423-1429.
14. Banks W.A., Jaspan J.B., Kastin A.J. Effect of diabetes mellitus on the permeability of the blood-brain barrier to insulin. Peptides 1997, 18(10):1577-1584.
15. Banks W.A., Kastin A.J. Differential permeability of the blood-brain barrier to two pancreatic peptides: Insulin and amylin. Peptides 1998, 19(5):883-889.
16. Banks W.A., Niehoff M.L., Martin D., Farrell C.L. Leptin transport across the blood-brain barrier of the Koletsky rat is not mediated by a product of the leptin receptor gene. Brain Research 2002, 950(1-2):130-136.
17. Banks W.A., Owen J.B., Erickson M.A. Insulin in the brain: There and back again. Pharmacology & Therapeutics 2012, 136(1):82-93.
18. Banting F.G., Best C.H., Collip J.B., Campbell W.R., Fletcher A.A. Pancreatic extracts in the treatment of diabetes mellitus. Canadian Medical Association Journal 1922, 12(3):141-146.
19. Barbu A., Johansson A., Bodin B., Kallskog O., Carlsson P.O., Sandberg M., et al. Blood flow in endogenous and transplanted pancreatic islets in anesthetized rats: Effects of lactate and pyruvate. Pancreas 2012, 41(8):1263-1271.
20. Baskin D.G., Porte D., Guest K., Dorsa D.M. Regional concentrations of insulin in the rat brain. Endocrinology 1983, 112(3):898-903.
21. Baskin D.G., Woods S.C., West D.B., van H.M., Posner B.I., Dorsa D.M., et al. Immunocytochemical detection of insulin in rat hypothalamus and its possible uptake from cerebrospinal fluid. Endocrinology 1983, 113(5):1818-1825.
22. Baura G., Foster D., Porte D., Kahn S.E., Bergman R.N., Cobelli C., et al. Saturable transport of insulin from plasma into the central nervous system of dogs in vivo: A mechanism for regulated insulin delivery to the brain. The Journal of Clinical Investigation 1993, 92:1824-1830.
23. Baura G., Foster D.M., Kaiyala K., Porte D., Kahn S.E., Schwartz M.W. Insulin transport from plasma into the central nervous system is inhibited by dexamethasone in dogs. Diabetes 1996, 45(1):86-90.
24. Begg D.P., Mul J.D., Liu M., Reedy B.M., D'Alessio D.A., Seeley R.J., et al. Reversal of diet-induced obesity increases insulin transport into cerebrospinal fluid and restores sensitivity to the anorexic action of central insulin in male rats. Endocrinology 2013, 154(3):1047-1054.
25. Begg D.P., Woods S.C. The endocrinology of food intake. Nature Reviews. Endocrinology 2013, 9(10):584-597.
26. Benedict C., Hallschmid M., Hatke A., Schultes B., Fehm H.L., Born J., et al. Intranasal insulin improves memory in humans. Psychoneuroendocrinology 2004, 29(10):1326-1334.
27. Benedict C., Hallschmid M., Schmitz K., Schultes B., Ratter F., Fehm H.L., et al. Intranasal insulin improves memory in humans: Superiority of insulin aspart. Neuropsychopharmacology 2007, 32(1):239-243.
28. Benedict C., Kern W., Schultes B., Born J., Hallschmid M. Differential sensitivity of men and women to anorexigenic and memory-improving effects of intranasal insulin. Journal of Clinical Endocrinology & Metabolism 2008, 93(4):1339-1344.
29. Benoit S.C., Air E.L., Coolen L.M., Strauss R., Jackman A., Clegg D.J., et al. The catabolic action of insulin in the brain is mediated by melanocortins. Journal of Neuroscience 2002, 22(20):9048-9052.
30. Bernstein I.L., Lotter E.C., Kulkosky P.J., Porte D., Woods S.C. Effect of force-feeding upon basal insulin levels of rats. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1975, 150:546-548.
31. Berthoud H.R., Bereiter D.A., Trimble E.R., Siegel E.G., Jeanrenaud B. Cephalic phase, reflex insulin secretion. Neuroanatomical and physiological characterization. Diabetelogia 1981, 20:393-401.
32. Bowen H., Mitchell T.D., Harris R.B. Method of leptin dosing, strain, and group housing influence leptin sensitivity in high-fat-fed weanling mice. American Journal of Physiology 2003, 284(1):R87-R100.
33. Brown L.M., Clegg D.J., Benoit S.C., Woods S.C. Intraventricular insulin and leptin reduce food intake and body weight in C57BL/6J mice. Physiology & Behavior 2006, 30:687-691.
34. Bruning J.C., Gautam D., Burks D.J., Gillette J., Schubert M., Orban P.C., et al. Role of brain insulin receptor in control of body weight and reproduction. Science 2000, 289(5487):2122-2125.
35. Campfield L.A., Blocker D.C. Simulation of the autonomic neural control of insulin secretion. Computers in Biology & Medicine 1979, 9(3):191-203.
36. Campfield L.A., Smith F.J. Neural control of insulin secretion: Interaction of norepinephrine and acetylcholine. American Journal of Physiology 1983, 244(5):R629-R634.
37. Campfield L.A., Smith F.J., Eskinazi R.E. Glucose responsiveness and acetylcholine sensitivity of pancreatic beta-cells after vagotomy. American Journal of Physiology 1984, 246(6 Pt. 2):R985-R993.
38. Campfield L.A., Smith F.J., Settle J.E., Sohaey R. Effect of the order of application of neural inputs on insulin secretion. Advances in Experimental Medicine & Biology 1986, 211:343-349.
39. Chavez M., Kaiyala K., Madden L.J., Schwartz M.W., Woods S.C. Intraventricular insulin and the level of maintained body weight in rats. Behavioral Neuroscience 1995, 109:528-531.
40. Chavez M., Riedy C.A., van Dijk G., Woods S.C. Central insulin and macronutrient intake in the rat. American Journal of Physiology 1996, 271:R727-R731.
41. Chavez M., Seeley R.J., Woods S.C. A comparison between effects of intraventricular insulin and intraperitoneal lithium chloride on three measures sensitive to emetic agents. Behavioral Neuroscience 1995, 109(3):547-550.
42. Clegg D.J., Benoit S.C., Reed J.A., Woods S.C., Dunn-Meynell A., Levin B.E. Reduced anorexic effects of insulin in obesity-prone rats fed a moderate-fat diet. American Journal of Physiology 2005, 288(4):R981-R986.
43. Clegg D.J., Brown L.M., Woods S.C., Benoit S.C. Gonadal hormones determine sensitivity to central leptin and insulin. Diabetes 2006, 55(4):978-987.
44. Clegg D.J., Gotoh K., Kemp C., Wortman M.D., Benoit S.C., Brown L.M., et al. Consumption of a high-fat diet induces central insulin resistance independent of adiposity. Physiology & Behavior 2011, 103(1):10-16.
45. Clegg D.J., Riedy C.A., Smith K.A., Benoit S.C., Woods S.C. Differential sensitivity to central leptin and insulin in male and female rats. Diabetes 2003, 52(3):682-687.
46. Considine R.V., Sinha M.K., Heiman M.L., Kriaucinas A., Stephens T.W., Nyce M.R., et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. The New England Journal of Medicine 1996, 334:292-295.
47. Cooper G.J., Willis A.C., Clark A., Turner R.C., Sim R.B., Reid K.B. Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proceeding of the National Academy of Sciences of the United States of America 1987, 84(23):8628-8632.
48. Craft S., Asthana S., Newcomer J.W., Wilkinson C.W., Matos I.T., Baker L.D., et al. Enhancement of memory in Alzheimer disease with insulin and somatostatin, but not glucose. Archieves of General Psychiatry 1999, 56(12):1135-1140.
49. Craft S., Baker L.D., Montine T.J., Minoshima S., Watson G.S., Claxton A., et al. Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: A pilot clinical trial. Archieves of Neurology 2012, 69(1):29-38.
50. Elgee N.J., Williams R.H., Lee N.D. Distribution and degradation studies with insulin I131. The Journal of Clinical Investigation 1954, 33(9):1252-1260.
51. Ezcurra M., Reimann F., Gribble F.M., Emery E. Molecular mechanisms of incretin hormone secretion. Current Opinion in Pharmacology 2013, 13(6):922-927.
52. Figlewicz D.P. Intraventricular insulin and leptin reverse place preference conditioned with high-fat diet in rats. Behavioral Neuroscience 2004, 118(3):479.
53. Fisher S.J., Bruning J.C., Lannon S., Kahn C.R. Insulin signaling in the central nervous system is critical for the normal sympathoadrenal response to hypoglycemia. Diabetes 2005, 54(5):1447-1451.
54. Floyd J.C., Fajans S.S., Conn J.W., Knopf R.F., Rull J. Stimulation of insulin secretion by amino acids. The Journal of Clinical Investigation 1966, 45(9):1487-1502.
55. Foster L.A., Ames N.K., Emery R.S. Food intake and serum insulin responses to intraventricular infusions of insulin and IGF-I. Physiology & Behavior 1991, 50(4):745-749.
56. Gribble F.M. The gut endocrine system as a coordinator of postprandial nutrient homoeostasis. Proceedings of the Nutrition Society 2012, 71(4):456-462.
57. Grillo C.A., Piroli G.G., Kaigler K.F., Wilson S.P., Wilson M.A., Reagan L.P. Downregulation of hypothalamic insulin receptor expression elicits depressive-like behaviors in rats. Behavioural Brain Research 2011, 222(1):230-235.
58. Grillo C.A., Tamashiro K.L., Piroli G.G., Melhorn S., Gass J.T., Newsom R.J., et al. Lentivirus-mediated downregulation of hypothalamic insulin receptor expression. Physiology & Behavior 2007, 92(4):691-701.
59. Hallschmid M., Benedict C., Schultes B., Born J., Kern W. Obese men respond to cognitive but not to catabolic brain insulin signaling. International Journal of Obesity 2008, 32(2):275-282.
60. Hallschmid M., Benedict C., Schultes B., Fehm H.L., Born J., Kern W. Intranasal insulin reduces body fat in men but not in women. Diabetes 2004, 53:3024-3029.
61. Haugaard N., Vaughan M., Haugaard E.S., Stadie W.C. Studies of radioactive injected labeled insulin. The Journal of Biological Chemistry 1954, 208(2):549-563.
62. Havrankova J., Brownstein M., Roth J. Insulin and insulin receptors in the rodent brain. Diabetologia 1981, 20:268-273.
63. Havrankova J., Roth J., Brownstein M.J. Concentrations of insulin and insulin receptors in the brain are independent of peripheral insulin levels. Studies of obese and streptozotocin treated rodents. The Journal of Clinical Investigation 1979, 64:632-642.
64. Havrankova J., Roth J., Browstein M. Insulin receptors are widely distributed in the central nervous system of the rat. Nature 1978, 272:827-829.
65. Helmstaedter V., Feurle G.E., Forssmann W.G. Insulin-, glucagon-, and somatostatin-immunoreactive endocrine cells in the equine pancreas. Cell and Tissue Research 1976, 172(4):447-454.
66. Hill J.M., Lesniak M.A., Pert C.B., Roth J. Autoradiographic localization of insulin receptors in rat brain: Prominence in olfactory and limbic areas. Neuroscience 1986, 17:1127-1138.
67. Hill J.W., Elias C.F., Fukuda M., Williams K.W., Berglund E.D., Holland W.L., et al. Direct insulin and leptin action on pro-opiomelanocortin neurons is required for normal glucose homeostasis and fertility. Cell Metabolism 2010, 11(4):286-297.
68. Ikeda H., West D.B., Pustek J.J., Figlewicz D.P., Greenwood M.R., Porte D., et al. Intraventricular insulin reduces food intake and body weight of lean but not obese Zucker rats. Appetite 1986, 7(4):381-386.
69. Israel P.A., Park C.R., Schwartz M.W., Green P.K., Sipols A.J., Woods S.C., et al. Effect of diet-induced obesity and experimental hyperinsulinemia on insulin uptake into CSF of the rat. Brain Research Bulletin 1993, 30:571-575.
70. Jaillard T., Roger M., Galinier A., Guillou P., Benani A., Leloup C., et al. Hypothalamic reactive oxygen species are required for insulin-induced food intake inhibition: An NADPH oxidase-dependent mechanism. Diabetes 2009, 58(7):1544-1549.
71. Jansson L., Hellerstrom C. Stimulation by glucose of the blood flow to the pancreatic islets of the rat. Diabetologia 1983, 25(1):45-50.
72. Kaiyala K., Prigeon R.L., Kahn S.E., Woods S.C., Schwartz M.W. Obesity induced by a high-fat diet is associated with reduced brain insulin transport in dogs. Diabetes 2000, 49:1525-1533.
73. Kaneto A., Kosaka K. Stimulation of glucagon and insulin secretion by acetylcholine infused intrapancreatically. Endocrinology 1974, 95(3):676-681.
74. Kastin A.J., Akerstrom V. Fasting, but not adrenalectomy, reduces transport of leptin into the brain. Peptides 2000, 21(5):679-682.
75. Kastin A.J., Pan W., Maness L.M., Koletsky R.J., Ernsberger P. Decreased transport of leptin across the blood-brain barrier in rats lacking the short form of the leptin receptor. Peptides 1999, 20:1449-1453.
76. Kelly C., McClenaghan N.H., Flatt P.R. Role of islet structure and cellular interactions in the control of insulin secretion. Islets 2011, 3(2):41-47.
77. Kimmel J.R., Hayden L.J., Pollock H.G. Isolation and characterization of a new pancreatic polypeptide hormone. The Journal of Biological Chemistry 1975, 250(24):9369-9376.
78. Kitamura T., Kahn C.R., Accili D. Insulin receptor knockout mice. Annual Review of Physiology 2003, 65:313-332.
79. Kreymann B., Ghatei M.A., Williams G., Bloom S.R. Glucagon-like peptide-1 7-36: A physiological incretin in man. Lancet 1987, 2:1300-1303.
80. Ku S.K., Lee H.S. Distribution and frequency of endocrine cells in the pancreas of the ddY mouse: An immunohistochemical study. European Journal of Histochemistry 2005, 49(2):125-130.
81. Lacroix M.C., Badonnel K., Meunier N., Tan F., Schlegel-Le Poupon C., Durieux D., et al. Expression of insulin system in the olfactory epithelium: First approaches to its role and regulation. Journal of Neuroendocrinology 2008, 20(10):1176-1190.
82. Langerhans P. Beitrage zur mikroscopischen anatomie der bauchspeichel druse 1869, Inaugural-dissertation, Gustav Lange, Berlin.
83. Leshan R.L., Greenwald-Yarnell M., Patterson C.M., Gonzalez I.E., Myers M.G. Leptin action through hypothalamic nitric oxide synthase-1-expressing neurons controls energy balance. Nature Medicine 2012, 18(5):820-823.
84. Levin B.E., Magnan C., Dunn-Meynell A., Le Foll C. Metabolic sensing and the brain: Who, what, where, and how?. Endocrinology 2011, 152(7):2552-2557.
85. Lifson N., Kramlinger K.G., Mayrand R.R., Lender E.J. Blood flow to the rabbit pancreas with special reference to the islets of Langerhans. Gastroenterology 1980, 79(3):466-473.
86. Marks D.R., Tucker K., Cavallin M.A., Mast T.G., Fadool D.A. Awake intranasal insulin delivery modifies protein complexes and alters memory, anxiety, and olfactory behaviors. The Journal of Neuroscience 2009, 29(20):6734-6751.
87. Marks J.L., Eastman C.J. Ontogeny of insulin binding in different regions of the rat brain. Developmental Neuroscience 1990, 12:349-358.
88. Marks J.L., Porte D., Stahl W.L., Baskin D.G. Localization of insulin receptor mRNA in rat brain by in situ hybridization. Endocrinology 1990, 127:3234-3236.
89. Matsumoto H., Rhoads D.E. Specific binding of insulin to membranes from dendrodendritic synaptosomes of rat olfactory bulb. Journal of Neurochemistry 1990, 54:347-350.
90. McGowan M.K., Andrews K.M., Grossman S.P. Chronic intrahypothalamic infusions of insulin or insulin antibodies alter body weight and food intake in the rat. Physiology & Behavior 1992, 51(4):753-766.
91. Mehran A.E., Templeman N.M., Brigidi G.S., Lim G.E., Chu K.Y., Hu X., et al. Hyperinsulinemia drives diet-induced obesity independently of brain insulin production. Cell Metabolism 2012, 16(6):723-737.
92. Morton G.J., Niswender K.D., Rhodes C.J., Myers M.G., Blevins J.E., Baskin D.G., et al. Arcuate nucleus-specific leptin receptor gene therapy attenuates the obesity phenotype of Koletsky (fa(k)/fa(k)) rats. Endocrinology 2003, 144(5):2016-2024.
93. Muller C., Voirol M.J., Stefanoni N., Surmely J.F., Jequier E., Gaillard R.C., et al. Effect of chronic intracerebroventricular infusion of insulin on brown adipose tissue activity in fed and fasted rats. International Journal of Obesity 1997, 21(7):562-566.
94. Musatov S., Chen W., Pfaff D.W., Mobbs C.V., Yang X.J., Clegg D.J., et al. Silencing of estrogen receptor {alpha} in the ventromedial nucleus of hypothalamus leads to metabolic syndrome. Proceeding of the National Academy of Sciences of the United States of America 2007, 104(7):2501-2506.
95. Obici S., Zhang B.B., Karkanias G., Rossetti L. Hypothalamic insulin signaling is required for inhibition of glucose production. Nature Medicine 2002, 8(12):1376-1382.
96. Okita M., Inui A., Baba S., Kasuga M. Central cholinergic regulation of pancreatic polypeptide secretion in conscious dogs. Journal of Endocrinology 1997, 154(2):311-317.
97. Pan W., Kastin A.J. Entry of EGF into brain is rapid and saturable. Peptides 1999, 20(9):1091-1098.
98. Pan W., Kastin A.J. TNFalpha transport across the blood-brain barrier is abolished in receptor knockout mice. Experimental Neurology 2002, 174(2):193-200.
99. Park C.R., Johnson L.H. Effect of insulin on transport of glucose and galactose into cells of rat muscle and brain. American Journal of Physiology 1955, 182(1):17-23.
100. Piper H.A., Allen R.S., Murlin J.R. Aqueous extracts of pancreas. II. Physical and chemical behavior of insulin. The Journal of Biological Chemistry 1923, 58(1):321.
101. Pontiroli A.E., Miele L., Morabito A. Increase of body weight during the first year of intensive insulin treatment in type 2 diabetes: Systematic review and meta-analysis. Diabetes, Obesity and Metabolism 2011, 13(11):1008-1019.
102. Porte D. Beta adrenergic stimulation of insulin release in man. Diabetes 1967, 16(3):150-155.
103. Porte D. A receptor mechanism for the inhibition of insulin release by epinephrine in man. The Journal of Clinical Investigation 1967, 46(1):86-94.
104. Porte D., Williams R.H. Inhibition of insulin release by norepinephrine in man. Science 1966, 152(3726):1248-1250.
105. Potes C.S., Turek V.F., Cole R.L., Vu C., Roland B.L., Roth J.D., et al. Noradrenergic neurons of the area postrema mediate amylin's hypophagic action. American Journal of Physiology 2010, 299(2):R623-R631.
106. Rahmouni K., Morgan D.A., Morgan G.M., Liu X., Sigmund C.D., Mark A.L., et al. Hypothalamic PI3K and MAPK differentially mediate regional sympathetic activation to insulin. The Journal of Clinical Investigation 2004, 114(5):652-658.
107. Samols E., Weir G.C. Adrenergic modulation of pancreatic A, B, and D cells alpha-Adrenergic suppression and beta-adrenergic stimulation of somatostatin secretion, alpha-adrenergic stimulation of glucagon secretion in the perfused dog pancreas. The Journal of Clinical Investigation 1979, 63(2):230-238.
108. Sanger F., Tuppy H. The amino-acid sequence in the phenylalanyl chain of insulin. 2. The investigation of peptides from enzymic hydrolysates. Biochemical Journal 1951, 49(4):481-490.
109. Sanger F., Tuppy H. The amino-acid sequence in the phenylalanyl chain of insulin. I. The identification of lower peptides from partial hydrolysates. Biochemical Journal 1951, 49(4):463-481.
110. Schaeffer M., Langlet F., Lafont C., Molino F., Hodson D.J., Roux T., et al. Rapid sensing of circulating ghrelin by hypothalamic appetite-modifying neurons. Proceeding of the National Academy of Sciences of the United States of America 2013, 110(4):1512-1517.
111. Schwartz M.W., Figlewicz D.P., Baskin D.G., Woods S.C., Porte D. Insulin in the brain: A hormonal regulator of energy balance. Endocrine Reviews 1992, 13:387-414.
112. Schwartz M.W., Woods S.C., Porte D., Seeley R.J., Baskin D.G. Central nervous system control of food intake. Nature 2000, 404:661-671.
113. Seeley R.J., van Dijk G., Campfield L.A., Smith F.J., Burn P., Nelligan J.A., et al. Intraventricular leptin reduces food intake and body weight of lean rats but not obese Zucker rats. Hormone and Metabolic Research 1996, 28(12):664-668.
114. Seeley R.J., Yagaloff K.A., Fisher S.L., Burn P., Thiele T.E., van Dijk G., et al. Melanocortin receptors in leptin effects. Nature 1997, 390(6658):349.
115. Shima K., Hirota M., Ohboshi C. Effect of glucagon-like peptide-1 on insulin secretion. Regulatory Peptides 1988, 22(3):245-252.
116. Shiraishi J., Yanagita K., Fukumori R., Sugino T., Fujita M., Kawakami S., et al. Comparisons of insulin related parameters in commercial-type chicks: Evidence for insulin resistance in broiler chicks. Physiology & Behavior 2011, 103(2):233-239.
117. Sims E.A., Danforth E., Horton E.S., Bray G.A., Glennon J.A., Salans L.B. Endocrine and metabolic effects of experimental obesity in man. Recent Progress in Hormone Research 1973, 29:457-496.
118. Sisley S., Sandoval D. Hypothalamic control of energy and glucose metabolism. Reviews in Endocrine and Metabolic Disorders 2011, 12(3):219-233.
119. Stein L.J., Dorsa D.M., Baskin D.G., Figlewicz D.P., Ikeda H., Frankmann S.P., et al. Immunoreactive insulin levels are elevated in the cerebrospinal fluid of genetically obese Zucker rats. Endocrinology 1983, 113(6):2299-2301.
120. Stephan F., Reville P., Thierry R., Schlienger J.L. Correlations between plasma insulin and body weight in obesity, anorexia nervosa and diabetes mellitus. Diabetologia 1972, 8:196-201.
121. Stockhorst U., de Fries D., Steingrueber H.J., Scherbaum W.A. Insulin and the CNS: Effects on food intake, memory, and endocrine parameters and the role of intranasal insulin administration in humans. Physiology & Behavior 2004, 83(1):47-54.
122. Stockhorst U., Huenig A., Ziegler D., Scherbaum W. Unconditioned and conditioned effects of intravenous insulin and glucose on heart rate variability in healthy men. Physiology & Behavior 2011, 103:31-38.
123. Strubbe J.H., Mein C.G. Increased feeding in response to bilateral injection of insulin antibodies in the VMH. Physiology & Behavior 1977, 19:309-313.
124. Strubbe J.H., Porte D.J., Woods S.C. Insulin responses and glucose levels in plasma and cerebrospinal fluid during fasting and refeeding in the rat. Physiology & Behavior 1988, 44:205-208.
125. Swann J.P. Insulin: A case study in the emergence of collaborative pharmacomedical research. Pharmacy in History 1986, 28(2):65-74.
126. Szecowka J., Lins P.E., Efendic S. Effects of cholecystokinin, gastric inhibitory polypeptide, and secretin on insulin and glucagon secretion in rats. Endocrinology 1982, 110(4):1268-1272.
127. Thiele T.E., Van Dijk G., Campfield L.A., Smith F.J., Burn P., Woods S.C., et al. Central infusion of GLP-1, but not leptin, produces conditioned taste aversions in rats. American Journal of Physiology 1997, 272(2 Pt. 2):R726-R730.
128. van der Heide L.P., Ramakers G.M., Smidt M.P. Insulin signaling in the central nervous system: Learning to survive. Progress in Neurobiology 2006, 79(4):205-221.
129. van Houten M., Posner B.I. Insulin binds to brain blood vessels in vivo. Nature 1979, 282(5739):623-625.
130. van Houten M., Posner B.I., Kopriwa B.M., Brawer J.R. Insulin-binding sites in the rat brain: In vivo localization to the circumventricular organs by quantitative radioautography. Endocrinology 1979, 105(3):666-673.
131. van Houten M., Posner B.I., Kopriwa B.M., Brawer J.R. Insulin binding sites localized to nerve terminals in rat median eminence and arcuate nucleus. Science 1980, 207:1081-1083.
132. von Mering J.V., Minkowski O. Diabetes Mellitus nach pankreasextirpation. Zbl Kiln Med 1889, 10:393-394.
133. Ward K.R., Bardgett J.F., Wolfgang L., Stocker S.D. Sympathetic response to insulin is mediated by melanocortin 3/4 receptors in the hypothalamic paraventricular nucleus. Hypertension 2011, 57(3):435-441.
134. Weatherford S.C., Ritter S. Lesion of vagal afferent terminals impairs glucagon-induced suppression of food intake. Physiology & Behavior 1988, 43(5):645-650.
135. Weisinger R.S., Stanley T.K., Begg D.P., Weisinger H.S., Spark K.J., Jois M. Angiotensin converting enzyme inhibition lowers body weight and improves glucose tolerance in C57BL/6J mice maintained on a high fat diet. Physiology & Behavior 2009, 98:192-197.
136. Westermark P., Wernstedt C., Wilander E., Hayden D.W., O'Brien T.D., Johnson K.H. Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells. Proceeding of the National Academy of Sciences of the United States of America 1987, 84(11):3881-3885.
137. Williams D.L., Baskin D.G., Schwartz M.W. Leptin regulation of the anorexic response to glucagon-like peptide-1 receptor stimulation. Diabetes 2006, 55(12):3387-3393.
138. 2+ homeostasis by islet endoplasmic reticulum and its role in insulin secretion. American Journal of Physiology 1988, 254(2 Pt. 1):E121-E136.
139. Woods S.C., Decke E., Vasselli J.R. Metabolic hormones and regulation of body weight. Psychological Review 1974, 81:26-43.
140. Woods S.C., Lotter E.C., McKay L.D., Porte D. Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons. Nature 1979, 282:503-505.
141. Woods S.C., Porte D. Insulin and the set-point regulation of body weight. Hunger: Basic mechanisms and clinical implications 1976, 273-280. Raven Press, New York, NY. D. Novin, G.A. Bray, W. Wyrwichka (Eds.).
142. Woods S.C., Porte D. Relationship between plasma and cerebrospinal fluid insulin levels of dogs. American Journal of Physiology 1977, 233(4):E331-E334.
143. Xaio H., Banks W.A., Niehoff M.L., Morley J.E. Effect of LPS on the permeability of the blood-brain barrier to insulin. Brain Research 2001, 896:36-42.
144. Young W.S.I., Kuhar M.J., Roth J., Brownstein M.J. Radiohistochemical localization of insulin receptors in the adult and developing rat brain. Neuropeptides 1980, 1:15-22.
145. Zhao W., Chen H., Xu H., Moore E., Meiri N., Quon M., et al. Brain insulin receptors and spatial memory. Correlated changes in gene expression, tyrosine phosphorylation, and signaling molecules in the hippocampus of water maze trained rats. The Journal of Biological Chemistry 1999, 274:34893-34902.